InvestorsHub Logo
Followers 42
Posts 1152
Boards Moderated 0
Alias Born 03/24/2021

Re: Catpole post# 181555

Wednesday, 07/12/2023 12:02:16 PM

Wednesday, July 12, 2023 12:02:16 PM

Post# of 198681
Well, if there's low float in SAGA while Biogenysis and Virogentics begin to create extraordinary value, the SAGA share price could do very well. :)

I wouldn't say I've been particularly negative, just trying to stay realistic, using the last few years of company performance as my point of reference. It's controversial to look at the more serious scenarios, but important due to ENZC's track record leading this, as well as SAGA's leadership history.

There would need to be a real paradigm shift in Biogenysis and Virogentics to begin delivering cures, not just safe harbor PRs, compared to the same subsidiaries managed by the same team under ENZC the last few years. The sky is the limit IF they can start delivering results. They've been maneuvering for awhile, so maybe it's time.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENZC News